Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Jounce Therapeutics, Inc. (JNCE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/05/2023 |
4
| Concentra Biosciences, LLC (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Acquired 10,000 shares
@ $9737.7, valued at
$97.4M
|
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Kamen Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Unknown transaction of 60,975 shares
@ $0
Unknown transaction of 33,875 shares
@ $0
Disposed/sold 10,840 options to buy
@ $9.56, valued at
$103.6k
Disposed/sold 13,550 options to buy
@ $7.92, valued at
$107.3k
Disposed/sold 15,700 options to buy
@ $4.46, valued at
$70k
Disposed/sold 15,700 options to buy
@ $7.58, valued at
$119k
Disposed/sold 15,700 options to buy
@ $7.27, valued at
$114.1k
Disposed/sold 20,000 options to buy
@ $2.8, valued at
$56k
|
|
| 05/04/2023 |
4
| Iannone Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Disposed/sold 31,400 options to buy
@ $7.19, valued at
$225.8k
Disposed/sold 7,850 options to buy
@ $7.58, valued at
$59.5k
Disposed/sold 15,700 options to buy
@ $7.27, valued at
$114.1k
Disposed/sold 20,000 options to buy
@ $2.8, valued at
$56k
|
|
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Diaz Luis (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Disposed/sold 27,100 options to buy
@ $14.78, valued at
$400.5k
Disposed/sold 10,163 options to buy
@ $7.92, valued at
$80.5k
Disposed/sold 15,700 options to buy
@ $4.46, valued at
$70k
Disposed/sold 15,700 options to buy
@ $7.58, valued at
$119k
Disposed/sold 15,700 options to buy
@ $7.27, valued at
$114.1k
Disposed/sold 20,000 options to buy
@ $2.8, valued at
$56k
|
|
| 04/06/2023 |
4
| MURRAY RICHARD /CA/ (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 39,228 shares
@ $1.85, valued at
$72.6k
|
|
| 03/14/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Bought 65,701 shares
@ $0.994, valued at
$65.3k
Bought 20,286 shares
@ $1.018, valued at
$20.7k
|
|
| 03/14/2023 |
3
| TANG KEVIN C (10% Owner) has filed a Form 3 on Jounce Therapeutics, Inc. |
| 01/11/2023 |
4
| Trehu Elizabeth (Chief Medical Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 4,159 shares
@ $1.1, valued at
$4.6k
Sold 5,126 shares
@ $1.12, valued at
$5.7k
|
|
| 01/11/2023 |
4
| MURRAY RICHARD /CA/ (CEO and President) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 20,191 shares
@ $1.1, valued at
$22.2k
Sold 24,879 shares
@ $1.12, valued at
$27.9k
|
|
| 01/11/2023 |
4
| Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 6,315 shares
@ $1.1, valued at
$6.9k
Sold 7,781 shares
@ $1.12, valued at
$8.7k
|
|
| 01/11/2023 |
4
| Cole Hugh M (COO) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 7,452 shares
@ $1.1, valued at
$8.2k
Sold 9,182 shares
@ $1.12, valued at
$10.3k
|
|
| 08/03/2022 |
4
| Cole Hugh M (COO) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 40,000 options to buy
@ $2.97, valued at
$118.8k
|
|
| 06/28/2022 |
4
| Salter-Cid Luisa (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.8, valued at
$56k
|
|
| 06/28/2022 |
4
| Raythatha Jigar (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.8, valued at
$56k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Kamen Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.8, valued at
$56k
|
|
| 06/28/2022 |
4
| Iannone Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.8, valued at
$56k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4/A
| Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 85,000 options to buy
@ $7.56, valued at
$642.6k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| MURRAY RICHARD /CA/ (CEO and President) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 87,500 shares
@ $0
Granted 175,000 options to buy
@ $7.56, valued at
$1.3M
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2022 |
4
| Trehu Elizabeth (Chief Medical Officer) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 3,005 shares
@ $7.3, valued at
$21.9k
Sold 5,378 shares
@ $6.65, valued at
$35.8k
|
|
|
|
|